Victory Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.12M Buy
3,560
+279
+9% +$329K 0.38% 43
2026
Q2
$3.94M Buy
3,281
+237
+8% +$242K 0.41% 36
2026
Q1
$2.8M Buy
3,044
+228
+8% +$231K 0.34% 46
2025
Q4
$3.03M Buy
2,816
+785
+39% +$751K 0.38% 45
2025
Q3
$1.56M Buy
2,031
+762
+60% +$567K 0.21% 60
2025
Q2
$990K Buy
1,269
+13
+1% +$10.1K 0.16% 73
2025
Q1
$1.04M Buy
1,256
+199
+19% +$166K 0.2% 61
2024
Q4
$816K Buy
+1,057
New +$875K 0.21% 60
2024
Q2
$575K Buy
635
+208
+49% +$166K 0.27% 41
2024
Q1
$332K Buy
427
+49
+13% +$34.9K 0.2% 41
2023
Q4
$220K Buy
+378
New +$221K 0.15% 59

Other funds holding LLY

Victory Financial Group's LLY Position: Q3 2026 in Review

Victory Financial Group increased its Eli Lilly (LLY) stake by 8.5% in Q3 2026, buying an estimated $329K and bringing the position to 3,560 shares worth $4.12M. The position accounts for 0.38% of the portfolio, ranked #43.

Victory Financial Group first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Victory Financial Group held 3,560 shares of Eli Lilly worth $4.12M as of Q3 2026.
  • Victory Financial Group bought 279 Eli Lilly shares in Q3 2026, an estimated $329K.
  • Eli Lilly made up 0.38% of Victory Financial Group's portfolio in Q3 2026, its #43 holding.
  • Victory Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Victory Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.